Rationale and prospects of combination therapy as a strategy for delaying antimalarial drug resistance.
Alexander
N D
ND
D000962:Antimalarials / Q000008:administration & dosage*; D002738:Chloroquine / Q000008:administration & dosage; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control; D008297:Male; D011322:Primary Prevention / Q000379:methods*; D011739:Pyrimethamine / Q000008:administration & dosage; D012680:Sensitivity and Specificity; D013413:Sulfadoxine / Q000008:administration & dosage
D000962:Antimalarials; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine